CEUS Fundamentals - Bubble Science 101
- Microbubbles (MBs):
- Gas-filled (e.g., Perfluorocarbon, $SF_6$) microspheres.
- Encapsulated by a shell (e.g., lipid, albumin, polymer).
- Size: 1-10 µm (similar to Red Blood Cells); remain strictly intravascular.
- Highly echogenic due to large acoustic impedance mismatch with blood.
- Mechanism of Action:
- MBs resonate (oscillate) when insonated by ultrasound waves.
- Emit non-linear harmonic signals, which are preferentially detected by the transducer.
- Harmonic imaging significantly improves signal-to-noise ratio and reduces artifacts.
- Can be intentionally destroyed by high Mechanical Index (MI) ultrasound pulses (useful for perfusion quantification).
- Key Advantages:
- Real-time dynamic assessment of vascularity and perfusion.
- No nephrotoxicity (safe in patients with renal impairment).
- No ionizing radiation.
⭐ Microbubbles are purely intravascular agents. Their inability to pass into the normal interstitium is crucial for differentiating vascular patterns and assessing perfusion dynamics, unlike iodinated or gadolinium-based contrast agents which can extravasate more readily into the extravascular extracellular space (EES).
Contrast Agents - The Bubbly Crew
- Composition & Size:
- Gas-filled microbubbles (2-10 µm).
- Shell: Lipid, albumin, polymer.
- Gas: Perfluorocarbons, $SF_6$.
- Key Properties:
- Strictly intravascular (no interstitial leakage).
- High echogenicity (impedance mismatch).
- Non-linear oscillation → harmonic imaging.
- Pharmacokinetics:
- Route: IV.
- Elimination: Gas exhaled (lungs); shell metabolized.
- Half-life: Short (minutes).
- Safety & Adverse Effects:
- Generally safe; no nephrotoxicity.
- ⚠️ Contraindications: Severe cardiopulmonary disease (R-L shunts, severe pulm HTN, unstable IHD).
- Rare: Headache, nausea; anaphylactoid reactions (very rare).
⭐ Purely intravascular, unlike CT/MRI agents; ideal for real-time perfusion imaging without interstitial leakage.
Technique & Phases - Dynamic Dance
- Injection & Imaging:
- IV bolus: Microbubble contrast agents (e.g., sulfur hexafluoride).
- Crucial: Low Mechanical Index (MI < 0.4) to preserve bubbles for dynamic scan.
- Continuous real-time visualization.
- Dynamic Phases (Sequential Assessment):
- Arterial Phase: 10-30 seconds post-injection. Shows early vascular filling, lesion hyperenhancement.
- Portal Venous Phase: 30-120 seconds. Peak organ (e.g., liver, spleen) parenchymal enhancement.
- Late Phase: >120 seconds (up to 4-6 minutes). Key for washout patterns (e.g., HCC vs. benign). 📌 Mnemonic: Always Probe Lesions (Arterial, Portal, Late)
⭐ CEUS is invaluable for characterizing focal liver lesions, especially when CT/MRI contrast is contraindicated (e.g., severe renal impairment, contrast allergy).
Clinical Applications - CEUS Detective

- Liver Lesion Characterization (Primary Use):
- Hepatocellular Carcinoma (HCC): APHE + portal/late phase washout (LR-M criteria).
- Metastases: Often rim APHE, then rapid & marked washout.
- Hemangioma: Peripheral nodular enhancement, centripetal fill (often incomplete on CEUS).
- Focal Nodular Hyperplasia (FNH): Spoke-wheel arterial filling, sustained enhancement in portal/late phases.
- Abscess: Honeycomb pattern, non-enhancing center, peripheral rim enhancement.
- Renal Lesions:
- Cystic vs. solid differentiation.
- RCC vascularity assessment.
- Other Key Areas:
- Splenic infarcts/lesions.
- Pancreatic lesion assessment.
- Trauma: Solid organ injury (liver, spleen, kidney).
- Vascular: Pseudoaneurysms, endoleaks, TIPS.
- Biopsy/ablation guidance.
⭐ Key advantage: Safe in renal impairment & contrast allergy, crucial for liver lesion workup when CECT/MRI contraindicated.
High‑Yield Points - ⚡ Biggest Takeaways
- CEUS uses microbubble contrast agents; strictly intravascular.
- Enables real-time dynamic assessment of tissue perfusion and vascularity.
- Key for characterizing focal liver lesions (e.g., FNH, HCC) and renal masses.
- Washout patterns (e.g., late washout in HCC) are critical for diagnosis.
- Safer profile than CT/MRI contrast; low nephrotoxicity and allergic reaction risk.
- Avoid in severe right-to-left cardiac shunts and severe pulmonary hypertension.
- Differentiates tumor thrombus from bland thrombus effectively.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app